Cancer Market Research Reports & Industry Analysis

Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.

Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.

The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.

Found 1203 publications
Neuroendocrine Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Neuroendocrine Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Mar, 2014 124 pages
Cervical Cancer Test Market & Patients - Pap Smear, HPV DNA, VIA – Test & Patients – Worldwide US$ 1,490.00

... are as follows 1. United Kingdom 2. France 3. Germany 4. Italy 5. Spain 6. Sweden 7. Switzerland 8. Norway 9. Netherlands 10. United States 11. Canada 12. Japan 13. Korea 14. Singapore 15. Malaysia 16. Australia 17. India 18. China 19. Thailand 20. Indonesia Data Sources This report is built using data ...

Apr, 2014 232 pages
Penile Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Penile Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Mar, 2014 69 pages
OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 US$ 5,995.00

OpportunityAnalyzer: Pancreatic Cancer - Opportunity Analysis and Forecasts to 2017 Summary With five-year survival only approximately 5%, pancreatic cancer is characterized as a disease with some of the highest unmet need in oncology. This report focuses on the current treatment landscape, unmet needs, ...

Mar, 2014 179 pages
Nasopharyngeal Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Nasopharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Mar, 2014 81 pages
Hormone-Sensitive Prostate Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014" provides data on the Hormone-Sensitive Prostate Cancer clinical trial scenario. This report provides elemental information and data ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Mar, 2014 84 pages
Cancer Stem Cell Trends: Market Research Report US$ 1,450.00

The report illustrates on the growing market for Cancer Stem Cells (CSCs) in the US and Europe The major factors stimulating the growth of ... from several human tumors such as brain, breast, colon and haematopoietic cancers. CSCs are believed to survive in tumors as a completely distinct population and might ...

Jan, 2014 23 pages
Non-small cell lung cancer: Game changing immunotherapies to revolutionise treatment - KOL Insight US$ 4,995.00

... of NSCLC treatments, development and competition, KOL Insight: Non-small cell lung cancer is an essential tool for keeping abreast of events that will ... of the Aerodigestive Oncology Translational Research THOR Cleveland Clinic Taussig Cancer Center, Ohio, USA. Dr Joan Shiller, deputy director of the Simmons ...

Mar, 2014 134 pages
Papillary Thyroid Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014' provides data on the Papillary Thyroid Cancer clinical trial scenario. This report provides elemental information and data relating ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Mar, 2014 91 pages
Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Trials Review, H1, 2014' provides data on the Human papillomavirus (HPV) Associated Cancer clinical trial scenario. This report provides elemental information and ... in each, along with the clinical trial scenario in BRIC nations Clinical trial (complete and in progress) data by phase, trial status, subjects ...

Mar, 2014 121 pages
Hormone Sensitive Breast Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014' provides data on the Hormone Sensitive Breast Cancer clinical trial scenario. This report provides elemental information and data ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Mar, 2014 170 pages
Hormone Refractory Breast Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014' provides data on the Hormone Refractory Breast Cancer clinical trial scenario. This report provides elemental information and data ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Mar, 2014 123 pages
The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ US$ 1,350.00

... the industry leaders are doing TODAY Within GMR Data’s 'The Cancer Drugs & Treatments Market - Data, Analysis & Forecasts to 2023’ we analyse the key ... and secondary research sources, GMR Data have interviewed leading cancer specialists within big pharma, R&D, wholesalers, distributors, marketeers and key ...

Nov, 2013 243 pages
Head and Neck Cancer Partnering 2009-2014 US$ 995.00

... and neck cancer partnering deals. The majority of deals are discovery or development stage whereby the licensee obtains a right or an option right to license ... access to the contract. Chapter 4 provides a comprehensive directory of head and neck cancer partnering deals signed and announced since 2009. The ...

Mar, 2014 150 pages
Cancer Gene Therapy Market Analysis US$ 1,800.00

... clinical development of drugs for treatment of multiple diseases. The initial studies of gene therapy were conducted mostly on monogenetic diseases, but the focus ... Involved with Application of Gene Therapy in Cancer Patients Regulatory Scenario for Gene Therapy Market Cancer Gene Therapy Drug Clinical Trial ...

Mar, 2014 300 pages
Hypopharyngeal Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Hypopharyngeal Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Feb, 2014 115 pages
Gastrointestinal Tract Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014' provides data on the Gastrointestinal Tract Cancer clinical trial scenario. This report provides elemental information and data relating ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Mar, 2014 413 pages
Duodenal Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Duodenal Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Mar, 2014 58 pages
Colon Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Colon Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Mar, 2014 120 pages
Cancer Molecular Biomarkers 2014: A Global Market Study US$ 3,090.00

... that regulate gene expression are, since these are at the core of cancer phenotypes. These developments have focused attention and established methods ... , provide information on the current and evolving use of molecular biomarkers and assist cancer drug developers, diagnostics companies and laboratory suppliers ...

Mar, 2014 153 pages
Cancer Molecular Diagnostics: Market Developments, Growth Areas and Opportunities US$ 3,090.00

... . Biopharm Reports assists suppliers in these key areas. Our specialised market studies are designed to assist laboratory suppliers to profile current and ... suppliers to sell into these markets, and support their innovation, development and strategic planning. Cancer Molecular Diagnostics 2014 involved the ...

Feb, 2014 153 pages
Lip Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... information and data relating to the clinical trials on Lip Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Feb, 2014 121 pages
Brain Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Brain Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Feb, 2014 122 pages
Bone Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Bone Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Feb, 2014 183 pages
Bladder Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... and data relating to the clinical trials on Bladder Cancer. It includes an overview of the trial numbers and their recruitment status as per the ... more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Feb, 2014 137 pages
Therapeutic Class Overview: Newer Oral Anti Androgens – Expanding Role in The Treatment Paradigm of Prostate Cancer US$ 2,500.00

... second generation antiandrogens (Androgen synthesis inhibitors/Androgen receptor inhibitors, Xtandi, ARN-509, ODM-021, Zytiga, TAK-700, TOK-001) to replace them ... This newer agents will expand these markets atleast by $10b ($6b in pre prostectomy, $4b nmCRPC) if get success. TAK-700 (Takeda), ARN-509 (JNJ) ...

Feb, 2014 44 pages
PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 US$ 9,995.00

PharmaPoint: Non-Small Cell Lung Cancer - Global Drug Forecast and Market Analysis to 2022 Summary Non-Small Cell Lung Cancer (NSCLC) is ... . Uptake will be driven by the drug’s promising clinical efficacy in both squamous and non-squamous patients and strong safety profile. After Iressa and Tarceva lose ...

Jun, 2013 375 pages
PharmaPoint: Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2022 US$ 9,995.00

PharmaPoint: Chronic Myeloid Leukemia (CML) - Global Drug Forecast and Market Analysis to 2022 Summary Chronic myeloid leukemia (CML) is a rare myeloproliferative ... . Analysis of the current and future market competition in the global CML market. Insightful review of the key industry drivers, restraints and ...

May, 2013 211 pages
Bile Duct Cancer (Cholangiocarcinoma) Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... Review, H1, 2014' provides data on the Bile Duct Cancer (Cholangiocarcinoma) clinical trial scenario. This report provides elemental information and data ... many more Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals ...

Feb, 2014 91 pages
AIDS - Related Cancer Global Clinical Trials Review, H1, 2014 US$ 2,500.00

... trial report, “AIDS - Related Cancer Global Clinical Trials Review, H1, 2014' provides data on the AIDS - Related Cancer clinical trial scenario. This ... Obtain discontinued trial listing for trials across the globe Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies ...

Feb, 2014 96 pages
Breast Cancer: New targeted therapies transform treatment - KOL Insight US$ 4,995.00

... ). Unique insider clinical opinion This new KOL Insight report Breast Cancer –new targeted therapies transform treatment provides everyone interested ... products, position and research. That is why FirstWord’s guarantee to keep Therapy Trends updated offers real commercial advantage. Consider the benefits ...

Feb, 2014 153 pages
2014 Strategies for the US Tumor Marker Testing Market US$ 9,700.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 620 pages and 103 tables

Jan, 2014 620 pages
2014 Strategies for the UK Tumor Marker Testing Market US$ 6,100.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 575 pages and 85 tables

Jan, 2014 575 pages
2014 Strategies for the Spanish Tumor Marker Testing Market US$ 6,100.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 565 pages and 85 tables

Jan, 2014 565 pages
2014 Strategies for the Japanese Tumor Marker Testing Market US$ 7,500.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 590 pages and 95 tables

Jan, 2014 590 pages
2014 Strategies for the German Tumor Marker Testing Market US$ 6,100.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 585 pages and 95 tables

Jan, 2014 585 pages
2014 Strategies for the Italian Tumor Marker Testing Market US$ 6,100.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 570 pages and 83 tables

Jan, 2014 570 pages
2014 Strategies for the French Tumor Marker Testing Market US$ 6,100.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 585 pages and 95 tables

Jan, 2014 585 pages
2014 Strategies for the US Hospital Tumor Marker Testing Market US$ 6,500.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 567 pages and 50 tables

Jan, 2014 567 pages
2014 Strategies for the UK Hospital Tumor Marker Testing Market US$ 3,850.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 527 pages and 37 tables

Jan, 2014 527 pages
2014 Strategies for the Spanish Hospital Tumor Marker Testing Market US$ 3,850.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 521 pages and 41 tables

Jan, 2014 521 pages
2014 Strategies for the Japanese Hospital Tumor Marker Testing Market US$ 4,850.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 537 pages and 42 tables

Jan, 2014 537 pages
2014 Strategies for the Italian Hospital Tumor Marker Testing Market US$ 3,850.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 525 pages and 38 tables

Jan, 2014 525 pages
2014 Strategies for the German Hospital Tumor Marker Testing Market US$ 3,850.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 530 pages and 40 tables

Jan, 2014 530 pages
2014 Strategies for the French Hospital Tumor Marker Testing Market US$ 3,850.00

... current and emerging suppliers, including their sales, market shares, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Business opportunities and strategic recommendations for suppliers. Contains 533 pages and 43 tables

Jan, 2014 533 pages
2014 Strategies for the Global Tumor Marker Testing Market: Sales Forecasts by Country and Strategic Profiles of Leading Suppliers US$ 3,500.00

... strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 104 pages and 3 tables

Jan, 2014 104 pages
2014 Strategies for the European Tumor Marker Testing Market US$ 19,700.00

... players and potential entrants; and suggests alternative business expansion strategies for suppliers. The cancer diagnostics market is on the verge of explosion ... basis of the disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly ...

Jan, 2014 820 pages
Competitive Intelligence 2014: Leading Cancer Diagnostics Market Players - Strategic Assessments of Major Suppliers and Emerging Market Entrants US$ 2,500.00

This new report from Venture Planning Group provides strategic assessments of major cancer diagnostic product suppliers and emerging market entrants. The report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product ...

Mar, 2014 80 pages
World Tumor Marker and Special Chemistry Testing Market 2014: US, Europe (France, Germany, Italy, Spain, UK), Japan US$ 8,500.00

... Hemoglobin, HCG, 25-Hydroxy Vitamin D2 and D3, Occult Blood, PAP, PSA, Thyroglobulin, Vitamin B-12 During the next decade, the tumor markers and ... as specimen preparation devices, controls, calibrators and others. 'World Tumor Markers and Special Chemistry Testing Market 2014: US, Europe (France, Germany, ...

Jan, 2014 320 pages
European Pap Smear/HPV Market 2014 US$ 2,850.00

... sales forecasts) $1,850. This report presents a detailed analysis of the Pap Smear/HPV testing market in Europe (France, Germany, Italy, Spain, UK), including clinical ... will further compound the growing demand for malignancy assays and the rapid market expansion worldwide. Contains 235 pages and 11 tables

Jan, 2014 235 pages
1 2 3 4 5 >
Skip to top